Bivalirudin

FDA Approved: * July 14, 2015
Pharm Company: * HOSPIRA INC
Category: Blood Thinner (Anticoagulant)

Bivalirudin (Bivalitroban[1]), sold under the brand names Angiomax and Angiox and manufactured by The Medicines Company, is a direct thrombin inhibitor (DTI).[2] Chemically, it is a synthetic congener of the naturally occurring drug hirudin, found in the saliva of the medicinal leech Hirudo medicinalis. Bivalirudin lacks many of the limitations seen with indirect thrombin inhibitors, such as heparin. A short, synthetic peptide, it is a potent and highly specifi... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Bivalirudin In 0.9% Sodium Chloride In 0.9% Sodium Chloride 250 mg/50ml Intravenous Injection
NDC: 0338-9572
Labeler:
Baxter Healthcare Corporation
Bivalirudin In 0.9% Sodium Chloride In 0.9% Sodium Chloride 500 mg/100ml Intravenous Injection
NDC: 0338-9576
Labeler:
Baxter Healthcare Corporation
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0409-8300
Labeler:
Hospira, Inc.
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0781-3158
Labeler:
Sandoz
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0781-9158
Labeler:
Sandoz
Bivalirudin 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 16729-275
Labeler:
Accord Healthcare, Inc.
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 25021-405
Labeler:
Sagent Pharmaceuticals
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 52958-034
Labeler:
Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Bivalirudin 250 mg Intracavernous Injection
NDC: 55111-652
Labeler:
Dr. Reddy's Laboratories Limited
Bivalirudin 250 mg Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 55150-210
Labeler:
Auromedics Pharma LLC

Related Brands

Drugs with the same active ingredients